Peptides DB

Research-centric peptide and protocol reference hub

Humanin vs Semaglutide

Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team

Humanin: Research use — not FDA-approvedSemaglutide: FDA-approved

A data-driven comparison of Humanin and Semaglutide (also searched as Semaglutide vs Humanin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

Humanin centers on metabolic, while Semaglutide leans toward metabolic. On indexed research, Humanin is ahead (Humanin: 5 studies, Preclinical; Semaglutide: 5, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • Humanin is strongest for metabolic; Semaglutide for metabolic.
  • Evidence: Humanin Preclinical (5 studies) vs Semaglutide Human clinical (5).
  • Check the FDA-approval status chips above before assuming a legal use pathway.

Effect profiles, overlaid

HealingMuscleMetabolicNeuroSleepInflammationSkin
HumaninSemaglutide

At a glance

HumaninPreclinical

Mitochondria-Derived Peptide | HN

Strongest: MetabolicStudies: 5Level: Moderate Research
SemaglutideHuman clinical

GLP-1 Receptor Agonist | Weight Loss & Diabetes

Strongest: MetabolicStudies: 5Level: FDA Approved

Humanin vs Semaglutide: side-by-side

MetricHumaninSemaglutide
ClassLongevityWeight Loss
Regulatory statusResearch use onlyFDA-approved
Evidence gradePreclinicalHuman clinical
Studies indexed55
Research levelModerate ResearchFDA Approved
Strongest effectMetabolic & appetiteMetabolic & appetite
Healing & recovery0.30.0
Muscle & body comp0.70.0
Metabolic & appetite1.75.0
Neuro & mood1.70.0
Sleep & circadian1.30.0
Inflammation & immune1.30.0
Skin & aesthetics0.04.0

▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).

Mechanism & pharmacokinetics

PropertyHumaninSemaglutide
MechanismGLP-1 receptor agonist
RouteSubcutaneous injection (oral form also available)
Half-life~7 days (≈165 h)
Time to peak1–3 days
Duration of actionWeekly dosing

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is Humanin?

Mitochondria-associated peptide explored for longevity, metabolic, and organ-protective effects.

Full Humanin profile, mechanism & studies →

What is Semaglutide?

### Semaglutide Summary Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its role in managing type 2 diabetes and obesity. Its efficacy in promoting weight loss and improving glycemic control has garnered significant attention in recent clinical research.

Full Semaglutide profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingHumanin0.3/5 effect signal
MuscleHumanin0.7/5 effect signal
MetabolicSemaglutide5.0/5 effect signal
NeuroHumanin1.7/5 effect signal
SleepHumanin1.3/5 effect signal
InflammationHumanin1.3/5 effect signal
SkinSemaglutide4.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack Humanin and Semaglutide?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

Humanin vs Semaglutide: side effects

Humanin

No community-reported effects logged yet.

Semaglutide
  • reduced appetite22
  • early satiety17
  • nausea9

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

Humanin has 5 approved studies indexed (Preclinical), and Semaglutide has 5 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is Humanin or Semaglutide better?

It depends on your goal. Humanin is strongest for metabolic; Semaglutide for metabolic. Humanin has more indexed studies (5). See the goal-by-goal breakdown above.

Is Humanin or Semaglutide better for weight loss?

Semaglutide shows the stronger metabolic & appetite profile (5.0/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.

Is Humanin or Semaglutide better for muscle?

Humanin leads on the muscle & body-composition axis (0.7/5).

Which has more research, Humanin or Semaglutide?

Humanin has 5 approved studies indexed (Preclinical); Semaglutide has 5 (Human clinical). Higher counts mean more to read, not proven superiority.

Can you stack Humanin and Semaglutide?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of Humanin vs Semaglutide?

Humanin: no community-reported effects logged yet. Semaglutide: reduced appetite, early satiety, nausea. These are anonymous reports, not incidence rates — see each profile.

Is Humanin or Semaglutide FDA-approved?

Humanin is a research-use compound and is not FDA-approved. Semaglutide is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is Semaglutide better than Humanin?

For metabolic, Semaglutide has the edge; for metabolic, Humanin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.